The evolving clinical use of prostate cancer biomarkers
Prostate Cancer Prostatic Dis
.
2022 Sep;25(3):386-387.
doi: 10.1038/s41391-022-00567-w.
Epub 2022 Jul 7.
Authors
Nathan L Samora
1
,
Jacob E Tallman
1
,
Jeffrey J Tosoian
2
3
Affiliations
1
Department of Urology, Vanderbilt University Medical Center, Nashville, TN, USA.
2
Department of Urology, Vanderbilt University Medical Center, Nashville, TN, USA. jeff.tosoian@vumc.org.
3
Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. jeff.tosoian@vumc.org.
PMID:
35798854
DOI:
10.1038/s41391-022-00567-w
No abstract available
Publication types
Editorial
MeSH terms
Biomarkers
Biomarkers, Tumor
Humans
Male
Prostate*
Prostatic Neoplasms* / diagnosis
Prostatic Neoplasms* / therapy
Substances
Biomarkers
Biomarkers, Tumor